GlaxoSmithKline Pakistan Market Cap

GlaxoSmithKline Pakistan has a market cap or net worth of 119.31 billion as of June 27, 2025. Its market cap has increased by 180.72% in one year.

Market Cap

119.31B

Enterprise Value

113.49B

Revenue

61.15B

Ranking

n/a

PE Ratio

14.73

Stock Price

374.65

Market Cap Chart

Since September 26, 1994, GlaxoSmithKline Pakistan's market cap has increased from 3.77B to 119.31B, an increase of 3,064.11%. That is a compound annual growth rate of 11.89%.

Market Cap History

Date	Market Cap	% Change
Jun 18, 2025	119.31B	-5.61%
Dec 31, 2024	126.40B	378.26%
Dec 29, 2023	26.43B	-5.45%
Dec 30, 2022	27.95B	-35.70%
Dec 31, 2021	43.47B	-28.84%
Dec 31, 2020	61.09B	19.47%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Abbott Laboratories (Pakistan)	94.57B
AGP Limited	52.69B
Highnoon Laboratories	50.86B
The Searle Company	45.14B
Shifa International Hospitals	29.30B
Citi Pharma	19.35B
Ferozsons Laboratories	16.26B
Otsuka Pakistan	3.65B

Market Cap Rankings